Trials / Completed
CompletedNCT03936374
A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants
A Study to Evaluate the Effect of Coadministration of a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of BMS-986205 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of multiple dose administrations of Omeprazole on the pharmacokinetics of BMS-986205.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986205 | Participants will receive BMS-986205 on Days 1 and 15 |
| DRUG | omeprazole | Participants will receive omeprazole on Days 10 to 15 |
Timeline
- Start date
- 2019-05-08
- Primary completion
- 2019-07-20
- Completion
- 2019-07-20
- First posted
- 2019-05-03
- Last updated
- 2019-09-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03936374. Inclusion in this directory is not an endorsement.